NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Continue to gaslight, as always. You have been unleashed at the front lines by the army to dangle Flaskworks carrot over the next several months! We will watch for your $90M annual revenue forecast BS, as we head to the first quarter post approval.

Let’s say NICE will approve $100k instead of $200k per patient. Why not take that now with manual production? NICE is not going to change their mind on how much they reimburse per patient whether NWBO uses Flaskworks or manual production.

At least NWBO wont be at the mercy of gofundme campaign or high net worth individuals who can afford such treatment, which will be a handful per month. With NICE support, that volume would at least be 5-10X, if not more.